Although propranolol was associated with a 30–50% improvement in pain and enhanced well-being for individuals with chronic myogenous TMD, its effect did not reach statistical significance compared to placebo; therefore, its use is not recommended [ 101 ].
← all excerpts
Diagnosis-based pathways for conservative and minimally invasive management of temporomandibular disorders: a scoping review.
1
—
—